Literature DB >> 15115604

Systemic administration of 17beta-estradiol reduces apoptotic cell death and improves functional recovery following traumatic spinal cord injury in rats.

Tae Y Yune1, Sun J Kim, Sang M Lee, Young K Lee, Young J Oh, Young C Kim, George J Markelonis, Tae H Oh.   

Abstract

Recent evidence indicates that estrogen exerts neuroprotective effects in both brain injury and neurodegenerative diseases. We examined the protective effect of estrogen on functional recovery after spinal cord injury (SCI) in rats. 17beta-estradiol (3, 100, or 300 microg/kg) was administered intravenously 1-2 h prior to injury (pre-treatment), and animals were then subjected to a mild, weight-drop spinal cord contusion injury. Estradiol treatment significantly improved hind limb motor function as determined by the Basso-Beattie-Bresnahan (BBB) locomotor open field behavioral rating test. Fifteen to 30 days after SCI, BBB scores were significantly higher in estradiol-treated (100 microg/kg) rats when compared to vehicle-treated rats. Morphological analysis showed that lesion sizes increased progressively in either vehicle-treated or 17beta-estradiol-treated spinal cords. However, in response to treatment with 17beta-estradiol, the lesion size was significantly reduced 18-28 days after SCI when compared to vehicle-treated controls. Terminal deoxynucleotidyl transferase-mediated UTP nickend labeling (TUNEL) staining and DNA gel electrophoresis revealed that apoptotic cell death peaked 24-48 h after injury. Also, SCI induced a marked increase in activated caspase-3 in the spinal cord, evident by 4 h after injury. However, administration of 17beta-estradiol significantly reduced the SCI-induced increase in apoptotic cell death and caspase-3 activity after SCI. Furthermore, 17beta-estradiol significantly increased expression of the anti-apoptotic genes, bcl-2 and bcl-x, after SCI while expression of the pro-apoptotic genes, bad and bax, was not affected by drug treatment. Finally, intravenous administration of 17beta-estradiol (100 microg/kg) immediately after injury (post-treatment) also significantly improved hind limb motor function 19-30 days after SCI compared to vehicle-treated controls. These data suggest that after SCI, 17 beta-estradiol treatment improved functional recovery in the injured rat, in part, by reducing apoptotic cell death.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15115604     DOI: 10.1089/089771504322972086

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  46 in total

1.  Neuroprotective effects of testosterone on motoneuron and muscle morphology following spinal cord injury.

Authors:  James S Byers; Anna L Huguenard; Dulanji Kuruppu; Nai-Kui Liu; Xiao-Ming Xu; Dale R Sengelaub
Journal:  J Comp Neurol       Date:  2012-08-15       Impact factor: 3.215

Review 2.  Estrogen and testosterone therapies in multiple sclerosis.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

3.  Nanoparticle Estrogen in Rat Spinal Cord Injury Elicits Rapid Anti-Inflammatory Effects in Plasma, Cerebrospinal Fluid, and Tissue.

Authors:  April Cox; Abhay Varma; John Barry; Alexey Vertegel; Naren Banik
Journal:  J Neurotrauma       Date:  2015-06-25       Impact factor: 5.269

4.  Protective Effects of Estradiol and Dihydrotestosterone following Spinal Cord Injury.

Authors:  Dale R Sengelaub; Qi Han; Nai-Kui Liu; Melissa A Maczuga; Violetta Szalavari; Stephanie A Valencia; Xiao-Ming Xu
Journal:  J Neurotrauma       Date:  2018-01-11       Impact factor: 5.269

5.  Low dose estrogen prevents neuronal degeneration and microglial reactivity in an acute model of spinal cord injury: effect of dosing, route of administration, and therapy delay.

Authors:  Supriti Samantaray; Joshua A Smith; Arabinda Das; Denise D Matzelle; Abhay K Varma; Swapan K Ray; Naren L Banik
Journal:  Neurochem Res       Date:  2011-05-25       Impact factor: 3.996

6.  Estrone is neuroprotective in rats after traumatic brain injury.

Authors:  Joshua W Gatson; Ming-Mei Liu; Kareem Abdelfattah; Jane G Wigginton; Scott Smith; Steven Wolf; James W Simpkins; Joseph P Minei
Journal:  J Neurotrauma       Date:  2012-05-08       Impact factor: 5.269

7.  Continuous tamoxifen delivery improves locomotor recovery 6h after spinal cord injury by neuronal and glial mechanisms in male rats.

Authors:  Jennifer M Colón; Pablo A González; Ámbar Cajigas; Wanda I Maldonado; Aranza I Torrado; José M Santiago; Iris K Salgado; Jorge D Miranda
Journal:  Exp Neurol       Date:  2017-10-13       Impact factor: 5.330

8.  Bioavailability effect of methylprednisolone by polymeric micelles.

Authors:  Ching-Lin Chen; Shwu-Fen Chang; Daniel Lee; Lang-Yo Yang; Yi-Hsuan Lee; Chung Y Hsu; Shwu-Jiuan Lin; Jiahorng Liaw
Journal:  Pharm Res       Date:  2007-11-08       Impact factor: 4.200

9.  Effect of endogenous androgens on 17beta-estradiol-mediated protection after spinal cord injury in male rats.

Authors:  Supatra Kachadroka; Alicia M Hall; Tracy L Niedzielko; Sukumal Chongthammakun; Candace L Floyd
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

Review 10.  Oxidative stress, DNA damage, and the telomeric complex as therapeutic targets in acute neurodegeneration.

Authors:  Joshua A Smith; Sookyoung Park; James S Krause; Naren L Banik
Journal:  Neurochem Int       Date:  2013-02-17       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.